Navigation
-
Advaxis Incorporated Receives $922,000 in Non-Dilutive Financing from the New Jersey Economic Development Authority
-
Advaxis Inc. to Present at the 7th Annual BIO Investor Forum
-
Advaxis Incorporated Provides Complete Response to FDA's Questions
-
Advaxis Incorporated Collaborates on Groundbreaking Listeria Moncoytogenes Immunotherapy Research Discovery
-
Advaxis Chief Executive Officer to Present at the 10th Annual World Vaccine Congress
-
Advaxis Incorporated's Board of Directors Approve Senior Promissory Note
-
Science Fiction Becomes Reality As Deadly Bacteria Battles Cancer
-
Advaxis' Dr. John Rothman to Present at the Bio International Convention in San Diego, CA
-
Advaxis Files Investigational New Drug Application with U.S. Food and Drug Administration
-
Advaxis Receives Research Coverage